In context
In late 2024, surgical robotics was expanding beyond traditional hospital operating rooms into outpatient and ambulatory surgery centers, driven by demand for cost-effective, space-efficient systems that integrate seamlessly into existing workflows. This shift was notable as most hernia repairs in the US were already performed in outpatient settings, yet robotic options remained largely tailored to inpatient use.
What was reported
Distalmotion's Dexter Surgical Robot successfully treated its first US patients in an outpatient setting on November 26, less than 30 days after receiving FDA De Novo marketing authorization. Two adult inguinal hernia repairs were completed at UC San Diego Health, with surgeons Garth R. Jacobsen and Ryan Broderick leading the procedures.
Dexter is designed to address barriers of cost, space, and workflow disruption in outpatient environments. Its mobile design, small form factor, and open platform allow integration with existing operating room equipment, protecting hospital investments. Single-use instruments eliminate reprocessing complexities, enhancing efficiency.
Unique to Dexter, the surgeon remains sterile at the console, enabling direct patient access during procedures. The system has treated over 1,400 patients in Europe, supporting its US market entry.
Why it mattered
This milestone demonstrated that robotic surgery can be effectively deployed in ambulatory settings, potentially expanding access to robotic-assisted procedures for high-volume, outpatient surgeries. It signaled a trend toward more flexible, cost-conscious robotic platforms that could reshape how surgical automation is adopted across diverse care sites.
“With over 90 percent of inguinal hernia repairs in the US performed in outpatient and ambulatory surgical settings, there is a need for robotic solutions tailored to these environments.”
Source: Robotics & Automation News (roboticsandautomationnews.com) · Published 2024-12-03 · “Distalmotion surgical robot used for first time in outpatients department”